HF
Hoxton Financial’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | $7K | Hold |
172
| – | – | ﹤0.01% | 272 |
|
|
2015
Q4 | $9K | Sell |
172
-162,361
| -100% | -$8.5M | ﹤0.01% | 241 |
|
|
2015
Q3 | $7.63M | Buy |
162,533
+81,352
| +100% | +$3.82M | 3.62% | 15 |
|
|
2015
Q2 | $10.1M | Sell |
81,181
-695
| -0.8% | -$86.7K | 4.2% | 11 |
|
|
2015
Q1 | $10.1M | Sell |
81,876
-4,865
| -6% | -$601K | 4.29% | 11 |
|
|
2014
Q4 | $9.37M | Sell |
86,741
-4,548
| -5% | -$491K | 3.91% | 11 |
|
|
2014
Q3 | $9.68M | Sell |
91,289
-1,355
| -1% | -$144K | 4.24% | 11 |
|
|
2014
Q2 | $9.62M | Sell |
92,644
-3,045
| -3% | -$316K | 4.11% | 11 |
|
|
2014
Q1 | $8.96M | Sell |
95,689
-7,768
| -8% | -$727K | 3.79% | 12 |
|
|
2013
Q4 | $9.1M | Buy |
+103,457
| New | +$9.1M | 3.92% | 12 |
|
|
2013
Q3 | – | Sell |
-110,489
| Closed | -$7.79M | – | 622 |
|
|
2013
Q2 | $7.79M | Buy |
+110,489
| New | +$7.79M | 4.4% | 10 |
|